Technical Analysis for ICO - iCo Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 0.085 -5.56% -0.005
ICO closed down 5.56 percent on Monday, November 11, 2019, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ICO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.56%
MACD Bullish Signal Line Cross Bullish -5.56%
Wide Bands Range Expansion -5.56%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.56%
Wide Bands Range Expansion -5.56%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.56%

Older signals for ICO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.
Health Biotechnology Clinical Trial
Is ICO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.145
52 Week Low 0.045
Average Volume 426,566
200-Day Moving Average 0.0815
50-Day Moving Average 0.106
20-Day Moving Average 0.0948
10-Day Moving Average 0.0885
Average True Range 0.0092
ADX 20.37
+DI 18.3529
-DI 21.4902
Chandelier Exit (Long, 3 ATRs ) 0.1074
Chandelier Exit (Short, 3 ATRs ) 0.1026
Upper Bollinger Band 0.1242
Lower Bollinger Band 0.0654
Percent B (%b) 0.33
BandWidth 62.025317
MACD Line -0.0053
MACD Signal Line -0.0052
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.085
Resistance 3 (R3) 0.085 0.085 0.085
Resistance 2 (R2) 0.085 0.085 0.085 0.085
Resistance 1 (R1) 0.085 0.085 0.085 0.085 0.085
Pivot Point 0.085 0.085 0.085 0.085 0.085
Support 1 (S1) 0.085 0.085 0.085 0.085 0.085
Support 2 (S2) 0.085 0.085 0.085 0.085
Support 3 (S3) 0.085 0.085 0.085
Support 4 (S4) 0.085